[Immunosuppressive therapy].
D000014:Abnormalities, Drug-Induced; D000470:Alkaloids / Q000627:therapeutic use; D000477:Alkylating Agents / Q000627:therapeutic use; D000937:Antigen-Antibody Reactions; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000276:immunology; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007114:Immunization; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008264:Macrophages / Q000276:immunology; D011247:Pregnancy; D013601:T-Lymphocytes / Q000276:immunology
D000470:Alkaloids; D000477:Alkylating Agents; D000961:Antilymphocyte Serum; D000963:Antimetabolites; D005938:Glucocorticoids; D007166:Immunosuppressive Agents
Immunsuppressive therapie.